TS Gene Polymorphisms Are Not Good Markers of Response to 5-FU Therapy in Stage III Colon Cancer Patients

Aim: Although the predictive and prognostic value of thymidylate synthase (TS) expression and gene polymorphism in colon cancer has been widely studied, the results are inconclusive probably because of methodological differences. With this study, we aimed to elucidate the role of TS gene polymorphis...

Full description

Saved in:
Bibliographic Details
Main Authors: A. Fariña-Sarasqueta, M. J. E. M. Gosens, E. Moerland, I. van Lijnschoten, V. E. P. P. Lemmens, G. D. Slooter, H. J. T. Rutten, A. J. C. van den Brule
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.3233/ACP-CLO-2010-0526
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832553943713972224
author A. Fariña-Sarasqueta
M. J. E. M. Gosens
E. Moerland
I. van Lijnschoten
V. E. P. P. Lemmens
G. D. Slooter
H. J. T. Rutten
A. J. C. van den Brule
author_facet A. Fariña-Sarasqueta
M. J. E. M. Gosens
E. Moerland
I. van Lijnschoten
V. E. P. P. Lemmens
G. D. Slooter
H. J. T. Rutten
A. J. C. van den Brule
author_sort A. Fariña-Sarasqueta
collection DOAJ
description Aim: Although the predictive and prognostic value of thymidylate synthase (TS) expression and gene polymorphism in colon cancer has been widely studied, the results are inconclusive probably because of methodological differences. With this study, we aimed to elucidate the role of TS gene polymorphisms genotyping in therapy response in stage III colon carcinoma patients treated with 5-FU adjuvant chemotherapy.
format Article
id doaj-art-615434059e2b4ace8b987a6aee8edfe7
institution Kabale University
issn 2210-7177
2210-7185
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series Analytical Cellular Pathology
spelling doaj-art-615434059e2b4ace8b987a6aee8edfe72025-02-03T05:52:44ZengWileyAnalytical Cellular Pathology2210-71772210-71852010-01-0133111110.3233/ACP-CLO-2010-0526TS Gene Polymorphisms Are Not Good Markers of Response to 5-FU Therapy in Stage III Colon Cancer PatientsA. Fariña-Sarasqueta0M. J. E. M. Gosens1E. Moerland2I. van Lijnschoten3V. E. P. P. Lemmens4G. D. Slooter5H. J. T. Rutten6A. J. C. van den Brule7PAMM Laboratory for Pathology, Eindhoven, The NetherlandsFontys University of Applied Science, Centre for Medical Molecular Diagnostics, Eindhoven, The NetherlandsPAMM Laboratory for Pathology, Eindhoven, The NetherlandsPAMM Laboratory for Pathology, Eindhoven, The NetherlandsComprehensive Cancer Centre South, Eindhoven, The NetherlandsDepartment of Surgery, Máxima Medical Centre Veldhoven, Veldhoven, The NetherlandsDepartment of Surgical Oncology, Catharina Hospital Eindhoven, Eindhoven, The NetherlandsPAMM Laboratory for Pathology, Eindhoven, The NetherlandsAim: Although the predictive and prognostic value of thymidylate synthase (TS) expression and gene polymorphism in colon cancer has been widely studied, the results are inconclusive probably because of methodological differences. With this study, we aimed to elucidate the role of TS gene polymorphisms genotyping in therapy response in stage III colon carcinoma patients treated with 5-FU adjuvant chemotherapy.http://dx.doi.org/10.3233/ACP-CLO-2010-0526
spellingShingle A. Fariña-Sarasqueta
M. J. E. M. Gosens
E. Moerland
I. van Lijnschoten
V. E. P. P. Lemmens
G. D. Slooter
H. J. T. Rutten
A. J. C. van den Brule
TS Gene Polymorphisms Are Not Good Markers of Response to 5-FU Therapy in Stage III Colon Cancer Patients
Analytical Cellular Pathology
title TS Gene Polymorphisms Are Not Good Markers of Response to 5-FU Therapy in Stage III Colon Cancer Patients
title_full TS Gene Polymorphisms Are Not Good Markers of Response to 5-FU Therapy in Stage III Colon Cancer Patients
title_fullStr TS Gene Polymorphisms Are Not Good Markers of Response to 5-FU Therapy in Stage III Colon Cancer Patients
title_full_unstemmed TS Gene Polymorphisms Are Not Good Markers of Response to 5-FU Therapy in Stage III Colon Cancer Patients
title_short TS Gene Polymorphisms Are Not Good Markers of Response to 5-FU Therapy in Stage III Colon Cancer Patients
title_sort ts gene polymorphisms are not good markers of response to 5 fu therapy in stage iii colon cancer patients
url http://dx.doi.org/10.3233/ACP-CLO-2010-0526
work_keys_str_mv AT afarinasarasqueta tsgenepolymorphismsarenotgoodmarkersofresponseto5futherapyinstageiiicoloncancerpatients
AT mjemgosens tsgenepolymorphismsarenotgoodmarkersofresponseto5futherapyinstageiiicoloncancerpatients
AT emoerland tsgenepolymorphismsarenotgoodmarkersofresponseto5futherapyinstageiiicoloncancerpatients
AT ivanlijnschoten tsgenepolymorphismsarenotgoodmarkersofresponseto5futherapyinstageiiicoloncancerpatients
AT vepplemmens tsgenepolymorphismsarenotgoodmarkersofresponseto5futherapyinstageiiicoloncancerpatients
AT gdslooter tsgenepolymorphismsarenotgoodmarkersofresponseto5futherapyinstageiiicoloncancerpatients
AT hjtrutten tsgenepolymorphismsarenotgoodmarkersofresponseto5futherapyinstageiiicoloncancerpatients
AT ajcvandenbrule tsgenepolymorphismsarenotgoodmarkersofresponseto5futherapyinstageiiicoloncancerpatients